Spotlight Asset Group »

Aurinia Pharmaceuticals shares owned by Spotlight Asset Group

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Spotlight Asset Group from 13F filings

Historical chart of Spotlight Asset Group investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Spotlight Asset Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Spotlight Asset Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $582 75 7.77
2023-09-30 $582 75 7.77
2023-06-30 $726 75 9.68

More positions owned by Spotlight Asset Group

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Meta Platforms Inc Cl A Stock (META)
Ishares S&p 500 Value Etf Etf (IVE)
Ishares Msci Eafe Etf Etf (EFA)
Opus Small Cap Value Etf Etf (OSCV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Growth Etf Etf (VUG)
Amazon Stock (AMZN)
Aptus Enhanced Yield Etf Etf (JUCY)
Gilead Sciences Stock (GILD)
Microsoft Corp Stock (MSFT)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)

View all positions for Spotlight Asset Group

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals